CONSUMER HEALTHCARE PRODUCTS ASSOCIATION for CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
S.150 - Affordable Prescriptions for Patients Act of 2023 Pandemic and All Hazards Preparedness Act Reauthorization Over-the-Counter access to oral contraception FDA Modernization Act 3.0 Dietary Supplement Listing Act Reauthorization of the Over the Counter Monograph User Fee Act (OMUFA) Wastewater Infrastructure Pollution Prevention and Environmental Safety Act or the WIPPES Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| KIRBY MILLER | — |
| MARC SCHLOSS | — |
| DAVID CHARLES SPANGLER | — |
Pharmacy PHA
OTC Switch - general advocacy on Prescription to Over-the-Counter Switch of medications and ingredients. Proposed rule for Nonprescription Drug Product with an Additional Condition for Nonprescription Use H.R. 2964/S. 1350 - The Wastewater Infrastructure Pollution Prevention and Environmental Safety Act or the WIPPES Act FDA Nonprescription Drugs Advisory Committee Meeting on Phenylephrine Activities related to Over-the-Counter Monograph Drug User Fee Drug Enforcement Administration Pseudoephedrine quotas
| Lobbyist | Covered position, as disclosed |
|---|---|
| KIRBY MILLER | — |
| MARC SCHLOSS | — |
| DAVID CHARLES SPANGLER | — |
Consumer Issues/Safety/Products CSP
H.R.1629 - Hemp and Hemp-Derived CBD Consumer Protection and Market Stabilization Act of 2023. H.R. 5374/S. 1843 - SHOP SAFE Act Dietary Supplement Reform issues H.R. 895 - Combatting Organized Retail Crime Act of 2023
| Lobbyist | Covered position, as disclosed |
|---|---|
| KIRBY MILLER | — |
| MARC SCHLOSS | — |
| DAVID CHARLES SPANGLER | — |
Taxation/Internal Revenue Code TAX
H.R. 4794 - Dietary Supplement Access Act H.R. 8599 - Oral Care Products Inclusion Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| KIRBY MILLER | — |
| MARC SCHLOSS | — |
| DAVID CHARLES SPANGLER | — |
Manufacturing MAN
Lobbying activities related to children's pain relieving medicines and supply chain. H.R. 3008 - Drug Shortage Prevention Act of 2023
| Lobbyist | Covered position, as disclosed |
|---|---|
| KIRBY MILLER | — |
| MARC SCHLOSS | — |
| DAVID CHARLES SPANGLER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.